30 day Acne Treatment Kit

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
30 day Acne Treatment Kit
Generic name
SALICYLIC ACID, BENZOYL PEROXIDE
Manufacturer
Cosmetic Enterprises Ltd
Product type
HUMAN OTC DRUG
SPL set ID
039ac054-3eb2-5beb-e063-6394a90a561a
SPL ID
40d391b1-a866-3128-e063-6394a90a2453
Version
4
Effective date
2025-10-10
Source export date
2026-10-12
Source partition
10
Source file
https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/befa34274042a52f589b22fe2add0b1c6f0a385c96447c28303de164bb144af5/drug-label-0010-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:30:41
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 2 matching rows.

warnings

Acne Cleanser Warnings: For external use only when using this product Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical medication at a time. Avoid contact with eyes, If contact occurs, flush thoroughly with water.

warnings

Acne Lotion Warnings: For external use only Do not use if you have very sensitive skin are sensitive to benzoyl peroxide. When using this product Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical medication at a time Avoid unnecess sun exposure and use a sunscreen Avoid contact with eyes, lips and mouth Avoid contact with hair and dyed fabrics, which may be bleached by this product Skin irritation may occur, characterized by redness, burning, itching, peeling, or possibly swelling. Irritation may be reduced by using the product less frequently or in lower concentration.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.